IL13 and Alzheimer disease: This can be explained by the fact that skin inflammation in AD is predominantly mediated by Th2 cytokines (IL-4, IL-13) in the acute phase of the disease [63] and that the Th2 cytokine milieu is known to suppress the production of the AMPs [124].